- $2.00bn
- $1.79bn
- $174.01m
Rover Group Inc expected to post a loss of 7 cents a share - Earnings Preview
Brief: Rover Group Files Prospectus Related To Class A Common Stock Offering Of Up To 91.5 Million Shares
Rover Group drops after disappointing revenue forecast
Rover Group Inc reports results for the quarter ended in December - Earnings Summary
Brief: Rover Says Q4 Revenue Rose 41%
Brief: Rover Says Vice President Of Finance Wickers to take over as CFO
Rover Group Inc expected to post a loss of 1cent a share - Earnings Preview
Rover Group Inc expected to post a loss of 1cent a share - Earnings Preview
Brief: Rover Announces Confirmation Of Previously Announced 2021 Revenue Guidance Ahead Of Participation At 24Th Annual Needham Virtual Growth Conference
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 04:13 PM
Brief: Rover Group, Inc. Announces Redemption Of All Outstanding Warrants
U.S. RESEARCH ROUNDUP-Caribou Biosciences, Immunogen, Supernus Pharmaceuticals
Rover rebounds after pricing downsized secondary offering
Brief: Rover Announces Pricing Of Follow-On Offering By Selling Stockholders
Rover trips after launching 11 mln share secondary offering
Brief: Rover Announces Launch Of Secondary Offering
Brief: Rover Group Inc Files For Offering Of Shares Of Co's Class A Common Stock By Selling Stockholders
Brief: Rover Announces Confidential Submission Of Draft Registration Statement For Secondary Offering
Rover Group Inc reports results for the quarter ended in September - Earnings Summary